{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:14:08Z","timestamp":1778602448959,"version":"3.51.4"},"reference-count":33,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"unspecified","delay-in-days":131,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013013","name":"Target ALS","doi-asserted-by":"publisher","award":["CF-2025-PMT"],"award-info":[{"award-number":["CF-2025-PMT"]}],"id":[{"id":"10.13039\/100013013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009797","name":"Barrow Neurological Foundation","doi-asserted-by":"publisher","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}],"id":[{"id":"10.13039\/100009797","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2026,2,2]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chitotriosidase (Chit-1) and chitinase-3-like protein 1 (CHI3L1) protein levels are increased in the cerebrospinal fluid (CSF) of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and Alzheimer\u2019s disease (AD). Few studies have examined the spatial expression of chitinase-expressing cells with respect to neuropathologic hallmarks of disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>RNA sequencing was used to examine Chit-1 and CHI3L1 gene expression in the spinal cord and motor cortex. Immunohistochemistry was used to characterise the distribution of Chit-1 and CHI3L1 expressing cells in ALS, C9-ALS, FTLD, AD and non-neurologic disease controls. Immunofluorescence confocal microscopy was used to correlate distribution of Chit-1 and CHI3L1 expressing cells to TDP-43 pathology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Chit-1 gene expression was increased in the spinal cord, and CHI3L1 expression was increased in both the spinal cord and motor cortex of patients with sALS and C9-ALS when compared with controls. Highest levels of Chit-1\n                      <jats:sup>+<\/jats:sup>\n                      glia were in cortical regions that contain hallmark neuropathology for each neurodegenerative disease. CHI3L1\n                      <jats:sup>+<\/jats:sup>\n                      glia were only significantly increased in sALS. Neither Chit-1\n                      <jats:sup>+<\/jats:sup>\n                      nor CHI3L1\n                      <jats:sup>+<\/jats:sup>\n                      glia was in close proximity to phosphorylated TDP-43 (pTDP) containing neurons in the motor cortex grey matter; however, there was a significant co-localisation of glial pTDP with Chit-1 and CHI3L1 in the motor cortex white matter.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Chit-1 and CHI3L1 expressing cells were most abundant in the white matter of cortical regions affected by each neurodegenerative disease and the spinal cord. Chit-1 or CHI3L1 expressing cells in the white matter often contained pTDP. We also observed correlations between levels of Chit-1 or CHI3L1 expressing cells in the white matter to disease duration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjno-2025-001225","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:45:21Z","timestamp":1778600721000},"page":"e001225","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["CHI3L1 (YKL-40) and Chit-1 expressing glia in the white matter of ALS, FTLD and AD: correlations to pathology and disease duration"],"prefix":"10.1136","volume":"8","author":[{"given":"Chelsea Mauri","family":"Tran","sequence":"first","affiliation":[{"name":"Department of Translational Neuroscience, Barrow Neurological Institute, Phoenix, Arizona, USA"},{"name":"School of Life Sciences, Arizona State University, Tempe, Arizona, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisha","family":"Reddy","sequence":"additional","affiliation":[{"name":"School of Life Sciences, Arizona State University, Tempe, Arizona, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J K","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Translational Neuroscience, Barrow Neurological Institute, Phoenix, Arizona, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinisha","family":"Venugopal","sequence":"additional","affiliation":[{"name":"Department of Translational Neuroscience, Barrow Neurological Institute, Phoenix, Arizona, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5404-7259","authenticated-orcid":false,"given":"Robert","family":"Bowser","sequence":"additional","affiliation":[{"name":"Department of Translational Neuroscience, Barrow Neurological Institute, Phoenix, Arizona, USA"},{"name":"School of Life Sciences, Arizona State University, Tempe, Arizona, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"2026051208451594000_8.1.e001225.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61156-7"},{"key":"2026051208451594000_8.1.e001225.2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/21678421.2014.897357","article-title":"Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale","volume":"15","author":"Balendra","year":"2014","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2026051208451594000_8.1.e001225.3","doi-asserted-by":"crossref","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"2026051208451594000_8.1.e001225.4","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl Neurodegener"},{"key":"2026051208451594000_8.1.e001225.5","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.13607"},{"key":"2026051208451594000_8.1.e001225.6","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000599"},{"key":"2026051208451594000_8.1.e001225.7","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-56124-1","article-title":"The Human Microglia Atlas (HuMicA) unravels changes in disease-associated microglia subsets across neurodegenerative conditions","volume":"16","author":"Martins-Ferreira","year":"2025","journal-title":"Nat Commun"},{"key":"2026051208451594000_8.1.e001225.8","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41593-019-0366-7","article-title":"Molecularly defined cortical astroglia subpopulation modulates neurons via secretion of Norrin","volume":"22","author":"Miller","year":"2019","journal-title":"Nat Neurosci"},{"key":"2026051208451594000_8.1.e001225.9","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/mds.26578","article-title":"Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson\u2019s Disease","volume":"31","author":"Hall","year":"2016","journal-title":"Mov Disord"},{"key":"2026051208451594000_8.1.e001225.10","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-317138"},{"key":"2026051208451594000_8.1.e001225.11","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000921","article-title":"Chitinases and chitinase-like proteins as biomarkers in neurologic disorders","volume":"8","author":"Pinteac","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2026051208451594000_8.1.e001225.12","doi-asserted-by":"crossref","DOI":"10.1186\/1559-0275-10-19","article-title":"Chitotriosidase - a putative biomarker for sporadic amyotrophic lateral sclerosis","volume":"10","author":"Varghese","year":"2013","journal-title":"Clin Proteomics"},{"key":"2026051208451594000_8.1.e001225.13","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.5b00804"},{"key":"2026051208451594000_8.1.e001225.14","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2019-320442"},{"key":"2026051208451594000_8.1.e001225.15","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2019-321916"},{"key":"2026051208451594000_8.1.e001225.16","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/acn3.51114","article-title":"CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis","volume":"7","author":"Gray","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"2026051208451594000_8.1.e001225.17","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00377","article-title":"The Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis: Signals From the CNS and Beyond","volume":"11","author":"Gaur","year":"2020","journal-title":"Front Neurol"},{"key":"2026051208451594000_8.1.e001225.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2010.08.025"},{"key":"2026051208451594000_8.1.e001225.19","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-020-1723-x","article-title":"Frontal cortex chitinase and pentraxin neuroinflammatory alterations during the progression of Alzheimer\u2019s disease","volume":"17","author":"Moreno-Rodriguez","year":"2020","journal-title":"J Neuroinflammation"},{"key":"2026051208451594000_8.1.e001225.20","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21154"},{"key":"2026051208451594000_8.1.e001225.21","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2007.070182"},{"key":"2026051208451594000_8.1.e001225.22","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0b013e31817713b5"},{"key":"2026051208451594000_8.1.e001225.23","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-013-1211-9"},{"key":"2026051208451594000_8.1.e001225.24","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25143"},{"key":"2026051208451594000_8.1.e001225.25","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.18632\/aging.101551","article-title":"YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression","volume":"10","author":"Andr\u00e9s-Benito","year":"2018","journal-title":"Aging (Milano)"},{"key":"2026051208451594000_8.1.e001225.26","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-319586"},{"key":"2026051208451594000_8.1.e001225.27","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.00006","article-title":"Unsuspected Involvement of Spinal Cord in Alzheimer Disease","volume":"14","author":"Lorenzi","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"2026051208451594000_8.1.e001225.28","doi-asserted-by":"crossref","first-page":"21595","DOI":"10.1038\/s41598-024-67389-9","article-title":"Progressive cervical cord atrophy parallels cognitive decline in Alzheimer\u2019s disease","volume":"14","author":"Emmenegger","year":"2024","journal-title":"Sci Rep"},{"key":"2026051208451594000_8.1.e001225.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2008.06.011"},{"key":"2026051208451594000_8.1.e001225.30","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-08140-7","article-title":"Chi3l3 induces oligodendrogenesis in an experimental model of autoimmune neuroinflammation","volume":"10","author":"Starossom","year":"2019","journal-title":"Nat Commun"},{"key":"2026051208451594000_8.1.e001225.31","first-page":"3012","article-title":"Astrocytes induce proliferation of oligodendrocyte progenitor cells via connexin 47-mediated activation of Chi3l1 expression","volume":"23","author":"Jiang","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2026051208451594000_8.1.e001225.32","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-318868"},{"key":"2026051208451594000_8.1.e001225.33","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jns.2014.12.016","article-title":"Chitotriosidase and lysosomal enzymes as potential biomarkers of disease progression in amyotrophic lateral sclerosis: a survey clinic-based study","volume":"348","author":"Pagliardini","year":"2015","journal-title":"J Neurol Sci"}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2025-001225","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:45:24Z","timestamp":1778600724000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2025-001225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,5,12]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/bmjno-2025-001225"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2025-001225","relation":{},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}